CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Down 49.8% in January

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 12,800 shares, a drop of 49.8% from the January 15th total of 25,500 shares. Based on an average trading volume of 177,200 shares, the days-to-cover ratio is presently 0.1 days.

CERo Therapeutics Stock Up 15.4 %

Shares of NASDAQ CEROW traded up $0.00 during midday trading on Friday, hitting $0.02. The company had a trading volume of 217,709 shares, compared to its average volume of 153,010. The business has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. CERo Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.